Q-omics provides the consensus-scored LINC00242 profile across patient tissues and cancer cell-line models. LINC00242 expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in UCS. Among the 18 cancer types available for tumor–normal comparison, LINC00242 is differentially expressed in 12, with the highest sampling consensus in KICH. Additionally, LINC00242 RNA expression shows 18,038 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight UCS, KICH, and UVM as cancer lineages where LINC00242 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC00242 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC00242 survival associations across molecular data types. LINC00242 RNA expression shows survival associations in the most cancer types (20), followed by mutation status (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC00242 RNA expression–survival associations across cancer types. High LINC00242 expression shows unfavorable associations in ACC, KIRP and KIRC, but favorable associations in UCS, PAAD and SKCM. The UCS Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify UCS as the clearest survival context for LINC00242 RNA expression.
This table summarizes LINC00242 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for LINC00242. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC00242 shows lower tumor expression in KICH and UCEC and higher tumor expression in THCA, HNSC, LUAD and KIRC. The KICH box plot shows higher LINC00242 RNA expression in normal versus tumor tissue (log2 FC = −0.550, t-test p < 0.001).
This table shows molecular features associated with LINC00242 in patient tissues and cancer cell lines. In patient samples, LINC00242 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set. In cancer cell lines, LINC00242 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in LUNG_NSCLC_LUAD, while CRISPR and shRNA rows add functional-dependency signals in CNS.
